Sarepta Therapeutics, Inc. (BMV:SRPT)
444.00
0.00 (0.00%)
At close: Oct 29, 2025
Sarepta Therapeutics Revenue
Sarepta Therapeutics had revenue of $611.09M USD in the quarter ending June 30, 2025, with 68.38% growth. This brings the company's revenue in the last twelve months to $2.48B, up 64.89% year-over-year. In the year 2024, Sarepta Therapeutics had annual revenue of $1.90B with 52.97% growth.
Revenue (ttm)
$2.48B
Revenue Growth
+64.89%
P/S Ratio
0.93
Revenue / Employee
$1.81M
Employees
1,372
Market Cap
43.55B MXN
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.90B | 658.64M | 52.97% |
| Dec 31, 2023 | 1.24B | 310.32M | 33.26% |
| Dec 31, 2022 | 933.01M | 231.13M | 32.93% |
| Dec 31, 2021 | 701.89M | 161.79M | 29.96% |
| Dec 31, 2020 | 540.10M | 159.27M | 41.82% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Wal-Mart de México | 1.00T |
| Arca Continental | 250.90B |
| Industrias Peñoles | 142.01B |
| Grupo Financiero Banorte | 134.12B |
| Grupo Elektra | 114.48B |
| GMéxico Transportes | 62.95B |
| Becle | 44.91B |
| Fibra UNO | 30.53B |